Liraglutide
Description
Liraglutide is an antidiabetic medicine used in the treatment of type 2 diabetes in adult patients. Patients are advised to follow a strict diet and exercise regimen along with this medicine for the best possible effect. This medicine is not recommended for use in patients with type 1 diabetes and diabetic ketoacidosis.
QUICK LINKS:
Side effects
Major & minor side effects for Liraglutide
- Bladder pain
- Loss of appetite
- Sweating
- Nausea and Vomiting
- Trouble sleeping
- Runny Nose
- Diarrhea
- Blurred vision
- Dizziness
- Nervousness
Uses of Liraglutide
What is it prescribed for?
- Diabetes Type 2
- Weight loss
Read More
Concerns
Commonly asked questions
- Onset of actionThe time required for this medicine to show its action is not clinically established.
- Duration of effectThe time until which this medicine remains active in the body is not clinically established.
- Safe with alcohol?Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
- Is it habit forming?No habit forming tendency has been reported.
- Usage in pregnancy?Use of this medicine in pregnant women is not recommended unless absolutely necessary. Discuss all the risks and benefits with your doctor before using this medicine.
- Usage while breast-feeding?Use of this medicine is not recommended in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before using this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.
Allergy
This medicine is not recommended for use in patients with a known allergy to liraglutide.
Medullary thyroid carcinoma
This medicine is not recommended for use in patients with a personal or family history of medullary thyroid carcinoma since the safety and efficacy of this medicine have not been established for such patients.
Multiple endocrine neoplasia type 2
This medicine is not recommended for use in patients with a known history of multiple endocrine neoplasia type 2 since the safety and efficacy of this medicine have not been established for such patients.
Warnings for special population
Pregnancy
Use of this medicine in pregnant women is not recommended unless absolutely necessary. Discuss all the risks and benefits with your doctor before using this medicine.
Breast-feeding
Use of this medicine is not recommended in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before using this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.
General warnings
Gastrointestinal blockage
This medicine should be used with extreme caution in patients suffering from gastrointestinal blockage due to the increased risk of severe side effects.
Pancreatitis
This medicine should be used with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis.
Thyroid Carcinoma
Liraglutide is not recommended for use in patients with a known history of Thyroid Carcinoma since the safety and efficacy of this medicine have not been established for such patients.
Missed Dose
If a dose of Liraglutide is missed, administer it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule. Do not double the dose to make up for the missed one.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
N/A
Instructions
Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects.
Interaction with Medicine
Clarithromycin
Ethinyl Estradiol
Ciprofloxacin
Salbutamol
Furosemide
Gatifloxacin
Disease interactions
Pancreatitis
This medicine should be administered with extreme caution in patients with a known history of pancreatitis due to the increased risk of recurrent pancreatitis. Report any symptoms such as abdominal pain, nausea, vomiting, etc. to the doctor immediately. Therapy with the medicine may be discontinued based on the clinical condition of the patient.
Thyroid Carcinoma
Liraglutide is not recommended for use in patients with a known history of Thyroid Carcinoma since the safety and efficacy of this medicine have not been established for such patients.
Renal Dysfunction
This medicine should be administered with extreme caution in patients with a history of kidney diseases due to the increased risk of worsening of the patient's condition. Close monitoring of kidney function is recommended for such patients. Replacement with a suitable alternative may be necessary based on the clinical condition.
Cardiovascular disease
This medicine should be administered with extreme caution in patients with a history of cardiovascular diseases due to the increased risk of worsening of the patient's condition. Close monitoring of heart function is recommended for such patients. Replacement with a suitable alternative may be necessary based on the clinical condition.
Liver Disease
This medicine should be administered with extreme caution in patients with a history of liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is recommended for such patients. Replacement with a suitable alternative may be necessary based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Administer Liraglutide injection with or without food. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous
How it works
This medicine works by increasing the levels of some natural substances. This results in lowering of the blood glucose levels.
Legal Status
Classification
Category
Incretin mimetics
Schedule
Schedule H
[Internet]. 2017 [cited 21 August 2017]. Available from:
DailyMed - SAXENDA- liraglutide injection, solution [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 21 August 2017]. Available from:
Liraglutide - DrugBank [Internet]. Drugbank.ca. 2017 [cited 21 August 2017]. Available from:
Liraglutide Injection: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 21 August 2017]. Available from:
Prescribing medicines in pregnancy database [Internet]. Therapeutic Goods Administration (TGA). 2017 [cited 21 August 2017]. Available from:
Information on this page was last updated on 4 Sep 2017
Disclaimer
We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.